Erin Lavelle - Net Worth and Insider Trading
Erin Lavelle Net Worth
The estimated net worth of Erin Lavelle is at least $83,223 dollars as of 2024-11-13. Erin Lavelle is the COO of Alder BioPharmaceuticals Inc and owns about 4,408 shares of Alder BioPharmaceuticals Inc (ALDR) stock worth over $83,223. Details can be seen in Erin Lavelle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Erin Lavelle has not made any transactions after 2019-04-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Erin Lavelle
Erin Lavelle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Erin Lavelle owns 2 companies in total, including Neoleukin Therapeutics Inc (NLTX) , and Climb Bio Inc (CLYM) .
Click here to see the complete history of Erin Lavelle’s form 4 insider trades.
Insider Ownership Summary of Erin Lavelle
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NLTX | Neoleukin Therapeutics Inc | 2022-05-12 | director |
| CLYM | Climb Bio Inc | 2021-08-09 | COO & CFO |
Erin Lavelle Latest Holdings Summary
Erin Lavelle currently owns a total of 1 stock. Erin Lavelle owns 4,408 shares of Alder BioPharmaceuticals Inc (ALDR) as of April 25, 2019, with a value of $83,223.
Latest Holdings of Erin Lavelle
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALDR | Alder BioPharmaceuticals Inc | 2019-04-25 | 4,408 | 18.88 | 83,223 |
Holding Weightings of Erin Lavelle
Erin Lavelle Form 4 Trading Tracker
According to the SEC Form 4 filings, Erin Lavelle has made a total of 0 transactions in Alder BioPharmaceuticals Inc (ALDR) over the past 5 years. The most-recent trade in Alder BioPharmaceuticals Inc is the sale of 1,434 shares on April 25, 2019, which brought Erin Lavelle around $19,603.
Insider Trading History of Erin Lavelle
- 1
Erin Lavelle Trading Performance
Erin Lavelle Ownership Network
Ownership Network List of Erin Lavelle
Ownership Network Relation of Erin Lavelle
Erin Lavelle Owned Company Details
What does Neoleukin Therapeutics Inc do?
Who are the key executives at Neoleukin Therapeutics Inc?
Erin Lavelle is the director of Neoleukin Therapeutics Inc. Other key executives at Neoleukin Therapeutics Inc include 10 percent owner Baker Bros. Advisors Lp , Principal Accounting Officer Sean Michael Smith , and Chief Medical Officer Priti Patel .
Neoleukin Therapeutics Inc (NLTX) Insider Trades Summary
Over the past 18 months, Erin Lavelle made no insider transaction in Neoleukin Therapeutics Inc (NLTX). Other recent insider transactions involving Neoleukin Therapeutics Inc (NLTX) include a net purchase of 2,285,342 shares made by Baker Bros. Advisors Lp , and a net sale of 1,323 shares made by Sean Michael Smith .
In summary, during the past 3 months, insiders sold 0 shares of Neoleukin Therapeutics Inc (NLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 66 shares of Neoleukin Therapeutics Inc (NLTX) were sold and 114,267 shares were bought by its insiders, resulting in a net purchase of 114,201 shares.
Neoleukin Therapeutics Inc (NLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Neoleukin Therapeutics Inc Insider Transactions
Erin Lavelle Mailing Address
Above is the net worth, insider trading, and ownership report for Erin Lavelle. You might contact Erin Lavelle via mailing address: C/o Alder Biopharmaceuticals, Inc., 11804 North Creek Parkway South, Bothell Wa 98011.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
